Tepezza Hearing Loss

In litigation Mass-tort payouts ($50k+) mass_tort · pharma

Tepezza hearing loss - MDL alleges the thyroid-eye-disease drug causes permanent hearing damage

Eligibility hint

Were treated with Tepezza infusions and developed hearing loss or tinnitus

Estimated payout range

$50,000 – $1,000,000

Current score

0.60 / 1.00

Official source

View source →

Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.

Recent signals

Horizon Therapeutics Faces Tepezza Lawsuits for Hearing Loss, Tinnitus - Drugwatch.com google_news · 2026-07-16
FDA adds new warning to Tepezza label - Eyes On Eyecare google_news · 2026-07-14
CL filing: IN RE: Air Crash at Muan International Airport, South Korea on December 29, 2024 courtlistener_search · 2026-07-08
CL filing: IN RE: Trans Union, LLC, Customer Data Security Breach Litigation courtlistener_search · 2026-07-08
CL filing: In re: Boyd Gaming Corp. Breach Litigation courtlistener_search · 2026-07-08
CL filing: IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation courtlistener_search · 2026-07-08
CL filing: CAPRICOR THERAPEUTICS, INC. v. NIPPON SHINYAKU CO., LTD. courtlistener_search · 2026-07-08
CL filing: IN RE: Nitrogen, Phosphorus, and Potassium (NPK) Fertilizer Antitrust Litigation courtlistener_search · 2026-07-08
CL filing: Plumbers' Welfare Fund, Local 130 U.A. v. Express Scripts, Inc. courtlistener_search · 2026-07-08
CL filing: Sagebrush Health Services v. Amgen Inc. courtlistener_search · 2026-07-08

Brands: horizon therapeuticsamgen
Products: tepezzateprotumumabthyroid eye diseasehearing losstinnitus

Frequently asked questions

Who qualifies for the Tepezza Hearing Loss case?

You may qualify if the following applies to you: Were treated with Tepezza infusions and developed hearing loss or tinnitus. Eligibility criteria can change as the case develops.

How much could a Tepezza Hearing Loss claim be worth?

Estimated payouts range from $50,000 to $1,000,000 depending on individual circumstances. These are estimates based on comparable outcomes, not guarantees.

What is the current status of the Tepezza Hearing Loss case?

In litigation. Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.

How do I check whether I'm included?

Take the free 30-second audit at https://www.getclaimscout.com/audit and claimscout matches the brands and products you've used against every active class action settlements and mass torts it tracks, or review the eligibility details at https://www.getclaimscout.com/matters/tepezza-hearing-loss.

Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.

Start audit →

Building an AI agent? This matter is available as JSON at https://www.getclaimscout.com/api/v1/matters/tepezza-hearing-loss, and the full registry is at /api/v1/matters. Agent quickstart: /llms.txt. Schema: /openapi.json.